about
Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapyCost-effectiveness and long-term impact of Helicobacter pylori 'test and treat' service in reducing open access endoscopy referrals.Isotope ratio mass spectrometry (IRMS) versus laser-assisted ratio analyzer (LARA): a comparative study using two doses of.Accuracy of a new ultrafast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive dyspeptic patients.Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjectsAccuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial.Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patientsNewer agents for Helicobacter pylori eradicationPeptic ulcer and Helicobacter pylori: update on testing and treatment.Can endoscopic atrophy predict histological atrophy? Historical study in United Kingdom and Japan.Efficacy of 5-ASA in the treatment of colonic diverticular disease.Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children.Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials.Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth.Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease.Tablet and oral liquid L-thyroxine formulation in the treatment of naïve hypothyroid patients with Helicobacter pylori infection.Rifabutin Triple Therapy is Effective in Patients With Multidrug-resistant Strains of Helicobacter pylori.Helicobacter pylori: diseases, tests and treatment.Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppressionA comparison amongst three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic.Sequential therapy for H. pylori: an 'aberrant' therapy ready for general use.Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population.Helicobacter pylori infection, anti-cagA antibodies and peptic ulcer: a case-control study in Italy.Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori.A rapid, low-dose, 13C-urea tablet for the detection of Helicobacter pylori infection before and after treatment.High eradication rates of Helicobacter pylori with a new sequential treatment.The clinical role of cytochrome p450 genotypes in Helicobacter pylori management.Best cut-off values for [14C]-urea breath tests for Helicobacter pylori detection.Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection.Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection.Accuracy of urea breath tests tablets after 10 minutes compared with standard 30 minutes to diagnose and monitoring Helicobacter pylori infection: a randomized controlled trial.High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study.A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses.Improving vital sign documentation at triage: an emergency department quality improvement project.Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori.Susceptibility of Helicobacter pylori to metronidazole.Meta-analysis: the efficacy of proton pump inhibitors for laryngeal symptoms attributed to gastro-oesophageal reflux disease.Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains.Treatment of Helicobacter pylori in Latin America.Commentary: Towards an effective and safe treatment of small intestine bacterial overgrowth.
P50
Q28296156-537FBABE-EFBD-47F6-BDCB-3F3673043034Q30482733-9B59BCCF-D8B3-48D1-B5B7-39D169960432Q30662021-BF429C79-12C9-4333-AC16-8E2B02D50923Q34020041-CD37652E-DD82-4C22-8019-30C46A50D3ADQ35596051-E880351E-CE4E-4306-BC6E-293A37A594B8Q35760442-812E0E54-9450-41CF-86FA-98E0E9245DA1Q35769214-40410EC4-CB99-4C58-97A0-07E3BFC296E8Q36071019-72106A51-34FF-48C9-91D2-EE050D89EB76Q36185526-8CD7F526-6C76-4FA0-B0E4-A29F4E9EB23FQ36360836-8745573A-0FE9-4222-A6CA-41481E217783Q37534132-23EDF3B6-B92D-4CF6-B61D-7F230DCE53C7Q37618534-FFA0CB37-5170-4314-8FC4-7200677132F3Q38238100-029F6305-5CBD-4BE7-B782-A669F06D40B5Q39081757-0440F576-A371-470E-BC73-75B6D89CEFD5Q39788221-BE4B5A45-7867-4545-BF78-280EE2A6BADDQ40450159-5679F3A0-5664-4AE0-8F1C-95A88A535001Q40690954-ACC2BAE0-1C6C-4581-A5FB-D7960CE8DEB0Q42170355-2E4AB2BC-47CB-465A-B730-D9D808A4CA4CQ42371575-7DEB3DB0-AD9F-4218-97E3-7D4EFB5720F8Q43191376-18E08CB6-EDA0-426F-ACE2-01E19A396B0AQ43553844-7467C581-6C5B-414B-BFD3-75A5ECB1B011Q43896137-E3A400F7-E0D3-49D0-9155-0BE514D2A917Q43967124-4DAE00F6-B7A7-4472-84A6-987602995F24Q44299920-5D2EFD48-7B76-4361-BB11-239C6B389C19Q44364926-640F5404-3CEC-4B0D-9B15-A1CF227F2218Q44364944-62116DE8-E99D-4ADF-BBA2-F36F13330035Q44480019-D4E5F81C-E4B1-4F4C-B8E9-07B1886F7D6CQ44700011-074C6718-EFB3-45F0-B465-2F31B49AB672Q44702306-AAFA689E-B9D1-47CA-B2B0-5EB26644AC68Q44884717-334AE7FC-F4C5-4FA4-8F85-3C6EDD4F45F3Q46034280-8AE08734-9442-4EB8-9C3C-EAF1CBBB1AB3Q46539036-49854592-2CDA-4274-94A0-233241D19BFFQ46552854-EA6678DC-BE00-4228-A11B-D0F700792B33Q50271904-BD7D13BE-9AD1-41A5-BD9F-700B5116CEAFQ51527259-1E6D044E-82B2-4492-9413-1C6594D0EEC3Q51808812-CEFC2654-564F-480D-8F6A-5E091F681E32Q53017018-88D6A61A-9B5F-4074-8CA9-191D53FC1DD5Q53702158-FDCC2C6D-FE93-4936-BA76-F4CB6CBD9F5DQ53984143-FB038314-6983-49B5-802B-9870543F1094Q54636548-A2F5C0A0-BF9A-4C6F-A9AB-DF59E58C77D0
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Luigi Gatta
@ast
Luigi Gatta
@en
Luigi Gatta
@es
Luigi Gatta
@nl
Luigi Gatta
@sl
type
label
Luigi Gatta
@ast
Luigi Gatta
@en
Luigi Gatta
@es
Luigi Gatta
@nl
Luigi Gatta
@sl
prefLabel
Luigi Gatta
@ast
Luigi Gatta
@en
Luigi Gatta
@es
Luigi Gatta
@nl
Luigi Gatta
@sl
P1053
S-6795-2016
P106
P1153
7005460253
P21
P31
P3829
P496
0000-0001-5789-3813